Liquid Drug Delivery Solutions

Düsseldorf, Germany, October 21, 2021. Gerresheimer's global presence in Europe, America and Asia at numerous certified own production sites enables regional and market-oriented cooperation and logistics with partners in the pharma world. At CPHI Worldwide in Milano the company will be presenting its innovative, solution-oriented and sustainable developments. The wide range of products includes solutions, products and delivery systems for drugs, vaccines or high potency biologics.

Latest news and innovations in the world of Gerresheimer. 

Moulded Glass Packaging Solutions

Gx® RTF vials are washed, packed in trays or in a nest and tub, sterilized and delivered to pharmaceuticals customers. They can then immediately begin filling without further procees steps. Gx RTF® Vials: flexibility through different packaging configurationshighest quality requirementshighest standards with regard to glass breakage, cosmetic defects, paricle contaminationDelivered sterilePackaging based on Ompi EZ-fill packaging formats: identically packaged sterile vials from to different manufacturers

One problem associated with syringe use is that traces of tungsten or other metals occasionally leave residue behind in the bore when the syringe cone is shaped. Gerresheimer developed a production technology registered for patent where the pin used to shape the cone is made of a special ceramic. So we can offer a metal-free 1 ml Gx RTF® Luer lock glass syringe. The process can be transferred to other Luer lock syringe sizes or to Luer cone syringes of various sizes at any time.

The syringes are made from COP (Cyclo Olefin Polymer). The needle syringes are glue-free as the cannula is not glued in, but is instead insert-molded during the injection molding process. No aggregation due to metal or tungsten residues, high viscosity silicone oil for reduced particles, minimal extractables and leachables, high pH tolerance, no shift in pH value, optimized permeation rate, high break resistance, tighter tolerances than glass, precise medication dosing thanks to minimal residue volume, wide variety of design options and high flexibility for customer-specific requirements, outstanding syringe functionality with regard to break loose, gliding forces and pull-off forces of the needle shield, compatible with auto injectors.

Prefillable glass syringes in bulk and "ready-to-fill" format, filling volumes of 0.5 to 5.0 ml, luer cone and luer lock systems, needle syringes, silicone-oil reduced and metal-free syringes for sensitive active ingredients, innovative syringe components.

With Gx InnoSafe, Gerresheimer offers a syringe with an integrated safety systems that prevents unintentional needle stick injuriesexcludes the possibility of accidental reuse andtakes the needs of pharmaceutical companies and end users equally into account.

From the concept development through industrialization to assembly, and pharmaceutical filling. We cover the entire spectrum of delivery types: inhaler, syringes, pen systems, auto injectors and infusion sets

Dedicated primary packaging for biological active ingredients : from reduced silicone- , and polymer syringes over ready-to-fill glass- and COP vials to customized product developments  and much more.

We have worldwide operations and about 10,000 employees manufacture our products in local markets, close to our customers. We have plants in Europe, North America, South America and Asia. This Whitepaper is a map of our worldwide locations.

Gx Biological Solutions offers enhanced services for pharmaceutical primary packaging in the US and in Europe.

Next to the primary packaging container itself services and data are needed, to proof usability and allow registration. Chemical, functionality, physical and regulatory aspects have to be covered in the complete value chain. Support on registration, lifecycle management, continuous improvement and more are offered by Gerresheimer. Let’s go through the capabilities of an experienced supplierThis webinar originally aired as part of Pharmapack Europe 2021

This video shows how we are transforming our company into a growth asset as an innovatins leader and solutions provider.